$ABEO insider trading
Over the last 12 months, Abeona Therapeutics insiders reported no purchases and 32 sales totaling $3.5M across SEC Form 4 filings. 12% of those filings were made under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $3.5M 32 events
- Events · 12m
- 32 Form 4 filings, grouped
- Insiders · 12m
- 9 distinct reporters
- 10b5-1 share
- 12% of events, not dollars
All insider trades
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | Alvino MarkD | ▼ Sale | 15,000 | $5.86 | $88K | -19.5% | — |
| Jul 21, 2026 | Vazzano Joseph WalterChief Financial Officer · O | ▼ Sale | 1,478 | $6.53 | $10K | -0.3% | — |
| Jul 9, 2026 | Vazzano Joseph WalterChief Financial Officer · O | ▼ Sale | 24,880 | $6.96 | $173K | -4.8% | — |
| Jul 9, 2026 | Seshadri VishwasChief Executive Officer · O·D | ▼ Sale | 67,971 | $6.96 | $473K | -4.9% | — |
| Jul 9, 2026 | O'Malley Brendan M.SVP, Chief Legal Officer · O | ▼ Sale | 12,050 | $6.96 | $84K | -2.7% | — |
| Jul 9, 2026 | Vasanthavada MadhavChief Commercial Officer · O | ▼ Sale | 12,606 | $6.96 | $88K | -4.2% | — |
| Jun 30, 2026 | Alland LeilaD | ▼ Sale | 11,000 | $5.92 | $65K | -6.3% | — |
| Jun 15, 2026 | Silverstein Christine BerniD | ▼ Sale | 18,160 | $5.71 | $104K | -13.2% | — |
| Jun 9, 2026 | O'Malley Brendan M.SVP, Chief Legal Officer · O | ▼ Sale | 11,131 | $5.36 | $60K | -2.5% | 2 tranches |
| Jun 9, 2026 | Vazzano Joseph WalterChief Financial Officer · O | ▼ Sale | 49,338 | $5.38 | $265K | -8.7% | plan · 3 tranches |
| Jun 9, 2026 | Vasanthavada MadhavChief Commercial Officer · O | ▼ Sale | 9,620 | $5.36 | $52K | -3.1% | 2 tranches |
| Jun 9, 2026 | Seshadri VishwasChief Executive Officer · O·D | ▼ Sale | 56,344 | $5.36 | $302K | -3.9% | 2 tranches |
| May 11, 2026 | Vasanthavada MadhavChief Commercial Officer · O | ▼ Sale | 5,548 | $5.96 | $33K | -1.7% | — |
| Mar 31, 2026 | Seshadri VishwasChief Executive Officer · O·D | ▼ Sale | 29,985 | $4.38 | $131K | -2.1% | plan |
| Mar 16, 2026 | Vazzano Joseph WalterChief Financial Officer · O | ▼ Sale | 785 | $4.76 | $4K | -0.1% | — |
| Feb 2, 2026 | Silverstein Christine BerniD | ▼ Sale | 20,070 | $5.09 | $102K | -12.7% | — |
| Feb 2, 2026 | Wuchterl Donald A.D | ▼ Sale | 14,814 | $5.09 | $75K | -8.1% | — |
| Feb 2, 2026 | Crombez EricD | ▼ Sale | 16,284 | $5.09 | $83K | -20.4% | — |
| Feb 2, 2026 | Alland LeilaD | ▼ Sale | 18,065 | $5.09 | $92K | -9.4% | — |
| Feb 2, 2026 | Alvino MarkD | ▼ Sale | 2,000 | $5.09 | $10K | -2.3% | — |
| Jan 22, 2026 | Vasanthavada MadhavChief Commercial Officer · O | ▼ Sale | 12,610 | $5.29 | $67K | -3.8% | — |
| Jan 22, 2026 | Vazzano Joseph WalterChief Financial Officer · O | ▼ Sale | 18,666 | $5.33 | $100K | -3.2% | — |
| Jan 22, 2026 | Seshadri VishwasChief Executive Officer · O·D | ▼ Sale | 69,832 | $5.33 | $372K | -4.6% | — |
| Jan 22, 2026 | O'Malley Brendan M.SVP, Chief Legal Officer · O | ▼ Sale | 13,578 | $5.33 | $72K | -2.9% | — |
| Jan 21, 2026 | Alvino MarkD | ▼ Sale | 13,500 | $5.23 | $71K | -21.7% | — |
| Dec 29, 2025 | Seshadri VishwasChief Executive Officer · O·D | ▼ Sale | 25,000 | $5.31 | $133K | -2.1% | plan |
| Nov 13, 2025 | Alvino MarkD | ▼ Sale | 15,000 | $4.74 | $71K | -19.4% | — |
| Oct 16, 2025 | Seshadri VishwasChief Executive Officer · O·D | ▼ Sale | 249 | $5.48 | $1K | — | — |
| Sep 30, 2025 | Seshadri VishwasChief Executive Officer · O·D | ▼ Sale | 44,274 | $5.31 | $235K | -3.6% | plan · 2 tranches |
| Sep 29, 2025 | O'Malley Brendan M.SVP, Chief Legal Officer · O | ▼ Sale | 9,366 | $5.39 | $51K | -2.6% | — |
| Sep 29, 2025 | Vazzano Joseph WalterChief Financial Officer · O | ▼ Sale | 9,035 | $5.39 | $49K | -2% | — |
| Sep 22, 2025 | O'Malley Brendan M.SVP, Chief Legal Officer · O | ▼ Sale | 688 | $5.43 | $4K | -0.2% | — |
| Aug 15, 2025 | Vazzano Joseph WalterChief Financial Officer · O | ▼ Sale | 15,000 | $7.36 | $110K | -3.1% | — |
| Aug 14, 2025 | Crombez EricD | ▼ Sale | 4,718 | $6.93 | $33K | -10% | — |
Every $ABEO filing on this page is one API call away
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Abeona Therapeutics filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $ABEO feed.